Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00276835 | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00470379 | Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery | completed | Early Phase 1 | 30 | Mayo ClinicOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01620749 | Of 18F MEL050 Using PET/CT in Metastatic Melanoma(MEL050) | unknown | Early Phase 1 | 12 | Cooperative Research Centre for Biomedical Imaging DevelopmentOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00580060 | Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity | completed | Early Phase 1 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00743353 | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5(K5) | completed | Early Phase 1 | 16 | Siemens Molecular ImagingINDUSTRY | 1 | Feb 2, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2015source: clinicaltrials